RecallRadar

FDA Drug recall D-0594-2018

Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc

On 2018-02-14 the FDA classified a Class II recall of Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc by Hetero Labs Unit Iii, citing CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0594-2018
ClassificationClass II
Statusterminated
Initiated2018-01-10
Published2018-02-14
Last updated2026-09-13 11:52 UTC
CompanyHetero Labs Unit Iii
DistributionNJ

Product

Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30

Reason

CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.

Identifiers

ndc31722-820-30
ndc31722-820-01
ndc31722-820-31
ndc31722-820-32
ndc31722-820-05
ndc31722-827-30
ndc31722-827-01
ndc31722-827-31
ndc31722-827-32
ndc31722-827-05
ndc31722-819-30
ndc31722-819-01
ndc31722-819-31
ndc31722-819-32
ndc31722-819-05
ndc31722-828-30
ndc31722-828-01
ndc31722-828-31
ndc31722-828-32
ndc31722-828-05
ndc31722-829-30
ndc31722-829-01
ndc31722-829-31
ndc31722-829-32
ndc31722-829-05
ndc31722-830-30
ndc31722-830-01
ndc31722-830-31
ndc31722-830-32
ndc31722-830-05
code_infoLot #: ARI17089, ARI17090, Exp. 5/2019

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0594-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.